← Leaderboards
Reshmi Parameswaran
Case Western Reserve University
$593,427
Attributed
$807,641
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $232.7K · FY2016–21$250K$187.5K$125K$62.5K$0
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$807,641 · 2
By mechanism
R21$807,641 · 2
Top collaborators
- Parameswaran Ramakrishnan2 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Walter F Boron$16,230,123
- Jinming Gao$19,330,906
- Michael F Romero$9,271,689
- Mark David Pagel$8,797,099
- Michael Gerard Zagorski$2,989,292
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularTherapeutic TargetProteinsBiologyPublic Health RelevanceSignal PathwayCellsGrowthIn VivoPathway InteractionsAntibodiesAdultPublishingResistanceCancer CellCell DeathChemotherapyChildBaseIn VitroLeukocytesOutcome ForecastExperimental StudyAntigen Targeting
Grant awards (4)
Novel molecular agents targeting NF-κB c-Rel O-GlcNAcylation for the treatment of acute myeloid leukemia.$232,677
R21 · FY2021 · CA
Novel molecular agents targeting NF-κB c-Rel O-GlcNAcylation for the treatment of acute myeloid leukemia.$195,752
R21 · FY2020 · CA
Targeting B cell activating factor receptor (BAFF-R) as a novel therapeutic strategy for drug resistant Acute Lymphoblastic Leukemia (ALL)$172,369
R21 · FY2017 · CA · contact PI
Targeting B cell activating factor receptor (BAFF-R) as a novel therapeutic strategy for drug resistant Acute Lymphoblastic Leukemia (ALL)$206,843
R21 · FY2016 · CA · contact PI